These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 5488178)
41. [Regulation of metabolism--a principle of cardi treatment]. Ehrlich R Z Allgemeinmed; 1969 Jun; 45(16):775-8. PubMed ID: 5816753 [No Abstract] [Full Text] [Related]
42. [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients]. Lekieffre J; Vaur L; Kacet S; Lacroix D Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):115-9. PubMed ID: 8494319 [TBL] [Abstract][Full Text] [Related]
46. [Results obtained with effervescent potassium in the treatment of definite myocardial changes]. García Otero V; García Fernández JL; Pescador del Hoyo L Rev Esp Cardiol; 1965 Apr; 18(2):238-50. PubMed ID: 5834379 [No Abstract] [Full Text] [Related]
48. Potassium, glucose, and insulin for arrhythmias in myocardial infarction. Mittra B Geriatrics; 1969 Mar; 24(3):125-43. PubMed ID: 5766036 [No Abstract] [Full Text] [Related]
49. [Preliminary report on the use of so-called electrolyte binders in myocardial infarct]. Stepantschitz G; Fröhlich E Wien Med Wochenschr; 1967 Sep; 117(39):884-9. PubMed ID: 5589342 [No Abstract] [Full Text] [Related]
50. [Therapy of some diseases of the myocardium with potassium aspartate]. Capritti AG Minerva Med; 1967 Apr; 58(33):1512-5. PubMed ID: 6026634 [No Abstract] [Full Text] [Related]
51. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias]. Zehender M Z Kardiol; 1996; 85 Suppl 6():135-45. PubMed ID: 9064958 [TBL] [Abstract][Full Text] [Related]
53. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041 [TBL] [Abstract][Full Text] [Related]
54. [Magnesium: a natural calcium antagonist]. Sviatov IS; Shilov AM Klin Med (Mosk); 1996; 74(3):54-6. PubMed ID: 8926707 [No Abstract] [Full Text] [Related]
55. [Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction]. Jiang XR; Chen WP; Shi HL; Zhou LF Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):36-9. PubMed ID: 6232818 [No Abstract] [Full Text] [Related]
56. [Ambulatory therapy of cardiac insufficiency with special reference to mineral metabolism]. Kastner H Med Welt; 1965 Nov; 46():2609-11. PubMed ID: 5885127 [No Abstract] [Full Text] [Related]
57. Serum potassium and sodium levels in coronary sinus blood in digitalis induced arrhythmias and its treatment with magnesium sulphate in dogs. Chandra R; Sikka KK; Lahiri V; Khan AH; Yadav NR J Assoc Physicians India; 1980 Jul; 28(7):159-64. PubMed ID: 7204316 [No Abstract] [Full Text] [Related]
58. Acute magnesium administration and frequency of ventricular arrhythmia in heart failure. Bradding P; Withers N Circulation; 1994 Nov; 90(5):2566. PubMed ID: 7955222 [No Abstract] [Full Text] [Related]
59. [Inderal (propanolol)-a new drug in the treatment of arrhythmia]. Johansson BW; Sievers J Lakartidningen; 1966 May; 63():Suppl 1:56-60. PubMed ID: 5913310 [No Abstract] [Full Text] [Related]
60. [On the treatment of the aging heart. Experiences with Coroverlan in so-called "geriatric cures" of the German Red Cross]. Schäfer G Med Welt; 1966 Jun; 25():1386-92. PubMed ID: 6010753 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]